-
Mashup Score: 23Clinical Research Associate - 5 month(s) ago
Clinical Research Associate
Source: jobs.ncl.ac.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2Job Advert - 1 year(s) ago
The Newcastle upon Tyne Hospitals NHS Foundation Trust The closing date is 28 May 2023 Job summary These fixed-term one-year posts would suit trainees who have a special interest in clinical and translational research and those who want to gain clinical research experience before a decision on pursuing an academic career. The post holders will…
Source: beta.jobs.nhs.ukCategories: Latest Headlines, Oncologists2Tweet-
Job for a clinical fellow helping with oncology trials @Newcastle_ECMC @Nuth_OHR. All previous incumbents have enjoyed themselves, built CVs and practiced baking amongst other skills https://t.co/JtxA4mseJV
-
-
Mashup Score: 2Personalised Assessment and Rapid Intervention in Frail Patients with Lung Cancer: The Impact of an Outpatient Occupational Therapy Service - 1 year(s) ago
Lung cancer and its treatments cause or accelerate frailty, detrimentally affecting function and quality of life. Occupational therapists (OTs) provid…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet-
Outstanding work from @jenny_welford. OT outpatient service for patients with #lcsm and frailty reduces admissions; improves advance Care planning, saves money. 👏 Personalised Assessment and Rapid Intervention in Frail Patients with ... https://t.co/U2qjzJlC4z
-
-
Mashup Score: 0Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet-
Delighted that MIST 2 published @TheLancetOncol. Showed activity of abemaciclib in mesothelioma with a putative biomarker of response. funded by @BlfResearch. #mesothelioma. @Newcastle_ECMC @NcccOncology https://t.co/tJThaks5aH
-
-
Mashup Score: 0
Background In the phase III PACIFIC study, durvalumab improved survival versus placebo in patients with unresectable stage III non-small-cell lung cancer (NSCLC) whose disease had not progressed after platinum-based concurrent chemoradiotherapy. The appraisal by the UK’s National Institute for Health and Care Excellence (NICE) included a cost-effectiveness analysis based on an early data readout…
Source: PharmacoEconomics - OpenCategories: Latest Headlines, Oncologists2Tweet-
👇 highlights utility of cancer drugs fund within work of @NICEComms. Allows early access when uncertainty about long term cost effectiveness. In potentially curative setting can safe lives. For durvalumab estimated 31-91 early deaths prevented https://t.co/spbcDiaXx6
-
Opportunity for PhDs @NU_Cancer @UniofNewcastle for clinicians interested in cancer. Part of our @CRUKresearch funded clinical academic training programme. @PasRescigno https://t.co/rNzFVGq8tG